How did GDRX's Q1 2025 EPS forecast compare to past trends?
4/3/2025 05:31pm
Goodrx's (GDRX) Q1 2025 EPS forecast of $0.04 is an improvement from the -$0.02 reported in Q1 2024 and a significant increase from the -$0.08 reported in Q1 2023. This indicates a potential turnaround and improvement in the company's financial performance.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|GDRX|GDRX.O|Goodrx|2022 Q1||0.03|185|
|GDRX|GDRX.O|Goodrx|2022 Q2|-100|0|185|
|GDRX|GDRX.O|Goodrx|2022 Q3|-150|-0.1|185|
|GDRX|GDRX.O|Goodrx|2023 Q1|-133.33333333333334|-0.01|185|
|GDRX|GDRX.O|Goodrx|2023 Q2||0.14|185|
|GDRX|GDRX.O|Goodrx|2023 Q3|10.000000000000009|-0.09|185|
|GDRX|GDRX.O|Goodrx|2024 Q1|100|0|185|
|GDRX|GDRX.O|Goodrx|2024 Q2|-85.71428571428571|0.02|185|
|GDRX|GDRX.O|Goodrx|2024 Q3|111.11111111111111|0.01|185|